Pharmaceuticals News and Research

RSS

Purdue Pharma announces agreement to end OxyContin patent lawsuit with Teva Pharmaceuticals

Purdue Pharma L.P. of Stamford, Connecticut and Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania have agreed to end their lawsuit concerning certain Purdue Pharma patents on OxyContin (oxycodone HCl controlled-release) Tablets.

30 Aug 2006

Ranbaxy wins two additional Atorvastatin patents in Norway

Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.

30 Aug 2006

Summary of editorials on approval of nonprescription plan B sales to women over age 18

Some editorials respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.

30 Aug 2006

Schering-Plough to pay $435M and plead guilty to conspiracy

Schering-Plough on Tuesday agreed to pay $435 million and plead guilty to criminal conspiracy charges to settle a federal investigation into the company's marketing practices and Medicaid charges, the AP/Houston Chronicle reports (AP/Houston Chronicle, 8/30).

30 Aug 2006

Kaiser report summarizes editorials on approval of nonprescription plan B sales to women over age 18

Some editorials and opinion pieces respond to FDA's decision on Thursday to approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older.

30 Aug 2006

Officials say PhRMA funded U.S. Chamber of Commerce ads touting Medicare prescription drug benefit

"[P]olitical officials" allege that the Pharmaceutical Research and Manufacturers of America gave money to the U.S. Chamber of Commerce to support an advertising campaign that praises senators and House members who voted for the 2003 Medicare law, the AP/San Jose Mercury News reports.

30 Aug 2006

Cellegy ends phase III microbicide trial in Nigeria

Cellegy Pharmaceuticals on Monday announced that it has ended phase Phase III clinical trials in Nigeria on its microbicide Savvy, the Philadelphia Inquirer reports (Loyd, Philadelphia Inquirer, 8/29).

30 Aug 2006

New York Times profiles Clinton's role in fight against HIV/AIDS

The New York Times on Tuesday profiled former President Clinton's role in the fight against HIV/AIDS in Africa, as well as in the rest of the world.

30 Aug 2006

FDA approves generic Ciprofloxacin injection

The Food and Drug Administration has approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corporation Pharmaceutical Division's CIPRO I.V., a drug to treat certain bacterial infections.

29 Aug 2006

Chinese scientists come up with safe and effective bird flu vaccine

According to official reports a bird flu vaccine for humans developed by Chinese researchers has proven to be both safe and effective.

29 Aug 2006

Waterborne infectious diseases could soon be consigned to history

Waterborne infectious diseases, which bring death and illness to millions of people around the world, could largely be consigned to history by 2015 if global health partnerships integrate their programmes, according to Alan Fenwick writing in Science.

28 Aug 2006

Australian girls lead the field in cervical cancer vaccination programme

Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.

28 Aug 2006

FDA approves nonprescription sales of Plan B for women over age 18

FDA on Thursday approved Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B to women ages 18 and older, the Washington Post reports.

24 Aug 2006

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

The National Women's Health Network has petitioned FDA to stop sales of Solvay's Estratest and Breckenridge Pharmaceuticals' Syntest, which are estrogen-testosterone combination therapies used to treat menopause-associated hot flashes, until they are proven safe and effective, Reuters reports.

24 Aug 2006

At last Plan B will be, but will von Eschenbach?

It has taken three years but at last the the controversial morning after pill, Plan B will finally be available to women in the U.S. without a prescription.

24 Aug 2006

Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung

Drug developers consider the lungs to be an excellent route through which to administer drugs.

21 Aug 2006

No matter how you do it tobacco is a killer

Regardless of how you do it, smoked or chewed, firsthand or secondhand, it seems all kinds of tobacco cause heart attacks.

21 Aug 2006

Groups that oppose abortion rights object to nomination of Von Eschenbach to permanently head FDA

Groups that oppose abortion rights are calling on President Bush to withdraw the nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency because FDA might approve Barr Laboratories' application for nonprescription sales of its emergency contraceptive Plan B for women ages 18 and older.

20 Aug 2006

HIV-positive people in developing countries risk having no antiretroviral treatment

Hundreds of thousands of HIV-positive people in developing countries in a few years will have no antiretroviral drug treatment unless more focus is placed on drug costs and access, HIV/AIDS advocates said Wednesday at the XVI International AIDS Conference in Toronto, Toronto's Globe and Mail reports.

20 Aug 2006

West Virginia family planning clinics about to run out of no-cost contraceptives

West Virginia-based family planning clinics can provide low-income women and students with no-cost contraceptive pills and patches for about one more month, the Charleston Gazette reports (Kelly, Charleston Gazette, 8/15).

17 Aug 2006

Pharmaceuticals News and Research

Purdue Pharma announces agreement to end OxyContin patent lawsuit with Teva Pharmaceuticals

Ranbaxy wins two additional Atorvastatin patents in Norway

Summary of editorials on approval of nonprescription plan B sales to women over age 18

Schering-Plough to pay $435M and plead guilty to conspiracy

Kaiser report summarizes editorials on approval of nonprescription plan B sales to women over age 18

Officials say PhRMA funded U.S. Chamber of Commerce ads touting Medicare prescription drug benefit

Cellegy ends phase III microbicide trial in Nigeria

New York Times profiles Clinton's role in fight against HIV/AIDS

FDA approves generic Ciprofloxacin injection

Chinese scientists come up with safe and effective bird flu vaccine

Waterborne infectious diseases could soon be consigned to history

Australian girls lead the field in cervical cancer vaccination programme

FDA approves nonprescription sales of Plan B for women over age 18

Women's Health Network petitions FDA to halt sales of estrogen, testosterone combination treatments

At last Plan B will be, but will von Eschenbach?

Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung

No matter how you do it tobacco is a killer

Groups that oppose abortion rights object to nomination of Von Eschenbach to permanently head FDA

HIV-positive people in developing countries risk having no antiretroviral treatment

West Virginia family planning clinics about to run out of no-cost contraceptives

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News